Φορτώνει......
Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis
BACKGROUND: Some people with multiple sclerosis (pwMS) are at increased risk of severe Coronavirus disease 19 (COVID-19) and should be rapidly vaccinated. However, vaccine supplies are limited, and there are concerns about side-effects, particularly with the ChAdOx1nCoV-19 (AstraZeneca) vaccine. OBJ...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Mult Scler Relat Disord |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Elsevier B.V.
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8129799/ https://ncbi.nlm.nih.gov/pubmed/34049216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.msard.2021.103028 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|